EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

Extended-phase anticoagulation for pediatric venous thromboembolism after EINSTEIN Jr

Nathan Wilken, Jun Teruya

Translational Pediatrics · 2026-06 · 15 (6) · 205-205

DOI: 10.21037/tp-2026-0193 ↗

Kurz gefasst

Editorial in der Zeitschrift Translational Pediatrics, 2026-06. Verfasst von Nathan Wilken und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Immunology, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

analysis of children aged 17 years or younger with acute VTE who had completed the initial anticoagulation phase of the EINSTEIN-Jr study. In the parent trial, children received 5–9 days of heparin therapy followed by randomization (2:1) to rivaroxaban or standard anticoagulation. After completing the acute treatment phase, participants were eligible for an extended anticoagulation phase. The extension phase constituted a non-randomized cohort in which the decision to continue anticoagulation was made at the discretion of the treating physician. Children could receive extended treatment within the study for up to 9 months (or up to 2 months in children younger than 2 years with catheter-related events), administered in predefined intervals, or could discontinue the study and continue anticoagulation outside the study setting. The primary outcomes, assessed among those who continued treatment within the study, were symptomatic recurrent VTE and clinically relevant bleeding. Within the EINSTEIN-Jr trial, 248 (51%) of 491

Schlagwörter

Stichwörter der Autor:innen

Anticoagulationpediatricvenous thromboembolism (VTE)

Autor:innen und Institutionen

  • Department of Pathology & Immunology, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.

Zitieren

APA

Wilken, N., & Teruya, J. (2026). Extended-phase anticoagulation for pediatric venous thromboembolism after EINSTEIN Jr. Translational Pediatrics, 15(6), 205-205. https://doi.org/10.21037/tp-2026-0193

Vancouver

Wilken N, Teruya J. Extended-phase anticoagulation for pediatric venous thromboembolism after EINSTEIN Jr. Translational Pediatrics. 2026;15(6):205-205. doi:10.21037/tp-2026-0193

BibTeX
@article{Wilken2026,
  author = {Wilken, Nathan and Teruya, Jun},
  title = {Extended-phase anticoagulation for pediatric venous thromboembolism after EINSTEIN Jr},
  journal = {Translational Pediatrics},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {205--205},
  doi = {10.21037/tp-2026-0193}
}
Kostenlos starten →